This article has been corrected to note that funding for the Stanford researchers came from NIGMS rather than NHGRI.

NEW YORK (GenomeWeb) – The National Institutes of Health has awarded two grants worth a total of $14 million to researchers at the Stanford University School of Medicine to expand two ongoing projects that support efforts to explore connections between genes and drug response.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.